TITLE

Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas

AUTHOR(S)
Uehara, H.; Nakaizumi, A.; Ishikawa, O.; Iishi, H.; Tatsumi, K.; Takakura, R.; Ishida, T.; Takano, Y.; Tanaka, S.; Takenaka, A.
PUB. DATE
November 2008
SOURCE
Gut;Nov2008, Vol. 57 Issue 11, p1561
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Synchronous occurrence of intraductal papillary mucinous neoplasm (IPMN) and ductal carcinoma of the pancreas has been reported. Branch duct IPMNs with lower likelihood of malignancy are not submitted to resection but are followed-up, so ductal carcinoma may develop during the follow-up. The development of ductal carcinoma of the pancreas during follow-up of branch duct IPMNs was investigated. Methods: 60 patients with branch duct IPMN who had an intraductal tumour of <10 mm on imaging examinations and a negative result for malignancy on cytological examination of the pancreatic juice were investigated. They were followed-up mainly by ultrasonography (US), and additionally by endoscopic ultrasonography )EUS), CT, magnetic resonance cholangiopancreatography )MRCP) or endoscopic retrograde cholangiopancreatography )ERCP) with cytological examination of the pancreatic juice for an average period of 87 months. Results: Ductal carcinoma of the pancreas distinct from IPMN developed in 5 of 60)8%) branch duct IPMNs during follow-up. The 5-year rate of development of ductal carcinoma was 6.9% (95% Cl 0.4% to 13.4%), the incidence of ductal carcinoma was 1.1% (95% Cl 0.1% to 2.2%) per year and the standardised incidence ratio of development of ductal carcinoma was 26)95% Cl 3 to 48). Patients >70 years old developed ductal carcinoma significantly more frequently than those under 69. Four of five ductal carcinomas identified during follow-up were resectable. Cancer developed in IPMN in 2 of 60 (3%) branch duct IPMNs during follow-up. Conclusions: During follow-up of branch duct IPMNs, ductal carcinoma of the pancreas not infrequently developed distinct from IPMN. In the follow-up of IPMN, special attention should be paid to the development of ductal carcinoma of the pancreas.
ACCESSION #
35151078

 

Related Articles

  • Diffusion-weighed MR imaging of pancreatic carcinoma. Matsuki, M.; Inada, Y.; Nakai, G.; Tatsugami, F.; Tanikake, M.; Narabayashi, I.; Masuda, D.; Arisaka, Y.; Takaori, K.; Tanigawa, N. // Abdominal Imaging;Jul/Aug2007, Vol. 32 Issue 4, p481 

    The aim of this study was to demonstrate the feasibility of body diffusion-weighted (DW) MR imaging in the evaluation of a pancreatic carcinoma. In nine normal volunteers and in eight patients with pancreatic carcinoma, DW images were obtained on the axial plane scanning with a multisection...

  • Erratum to: Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging. Kim, Hyunki; Arnoletti, Pablo; Christein, John; Heslin, Martin; Posey, James; Pednekar, Amol; Beasley, T.; Morgan, Desiree // Abdominal Imaging;Oct2014, Vol. 39 Issue 5, p1143 

    No abstract available.

  • Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients. Hayano, Koichi; Miura, Fumihiko; Amano, Hodaka; Toyota, Naoyuki; Wada, Keita; Kato, Kenichiro; Sano, Keiji; Takeshita, Koji; Aoyagi, Tomoyoshi; Shuto, Kiyohiko; Matsubara, Hisahiro; Asano, Takehide; Takada, Tadahiro // Journal of Hepato -- Biliary -- Pancreatic Sciences;Feb2013, Vol. 20 Issue 2, p243 

    Background/purpose: The aim of this study was to evaluate the clinical usefulness of diffusion-weighted magnetic resonance imaging (DWI) in patients with pancreatic cancer by comparing the apparent diffusion coefficient (ADC) value with clinicopathologic features. Methods: Twenty-two consecutive...

  • Quantitative functional MRI in a clinical orthotopic model of pancreatic cancer in immunocompetent Lewis rats. Zhuoli Zhang; Linfeng Zheng; Weiguo Li; Gordon, Andrew C.; Yi Huan; Shangguan, Junjie; Procissi, Daniel; Bentrem, David J.; Larson, Andrew C. // American Journal of Translational Research;2015, Vol. 7 Issue 9, p1475 

    Objective: To demonstrate feasibility of performing quantitative MRI measurements in an immuno-competent rat model of pancreatic cancer by comparing in vivo anatomic and quantitative imaging measurements to tumor dissemination observations and histologic assays at necropsy. Meterials and...

  • Predictive value of T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial invasion in endometrial cancer: a pooled analysis of prospective studies. Wu, Lian-Ming; Xu, Jian-Rong; Gu, Hai-Yan; Hua, Jia; Haacke, E.; Hu, Jiani // European Radiology;Feb2013, Vol. 23 Issue 2, p435 

    Background: To obtain diagnostic performance values of T2-weighted imaging (T2WI) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the prediction of myometrial invasion in patients with endometrial cancer. Methods: Databases including MEDLINE and EMBASE were searched for relevant...

  • DWI of Prostate Cancer: Optimal b-Value in Clinical Practice. Manenti, Guglielmo; Nezzo, Marco; Chegai, Fabrizio; Vasili, Erald; Bonanno, Elena; Simonetti, Giovanni // Prostate Cancer (20903111);2014, p1 

    Aim. To compare the diagnostic performance of diffusion weighted imaging (DWI) using b-values of 1000 s/mm2 and 2000 s/mm2 at 3 Tesla (T) for the evaluation of clinically significant prostate cancer. Matherials and Methods. Seventy-eight prostate cancer patients underwent a 3T MRI scan followed...

  • Differentiation of Autoimmune Pancreatitis From Pancreatic Cancer by Diffusion-Weighted MRI. Kamisawa, Terumi; Takuma, Kensuke; Anjiki, Hajime; Egawa, Naoto; Hata, Tastuo; Kurata, Masanao; Honda, Goro; Tsuruta, Kouji; Suzuki, Mizuka; Kamata, Noriko; Sasaki, Tsuneo // American Journal of Gastroenterology;Aug2010, Vol. 105 Issue 8, p1870 

    OBJECTIVES:We sought to clarify the clinical utility of diffusion-weighted magnetic resonance imaging (DWI) for differentiating autoimmune pancreatitis (AIP) from pancreatic cancer.METHODS:Thirteen AIP patients underwent DWI before therapy, and six of them underwent DWI after steroid therapy....

  • Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy. Niwa, T.; Ueno, M.; Ohkawa, S.; Yoshida, T.; Doiuchi, T.; Ito, K.; Inoue, T. // British Journal of Radiology;Jan2009, Vol. 82 Issue 973, p28 

    The purpose of this study was to determine if the apparent diffusion coefficient (ADC) on diffusion-weighted MRI could predict the response of patients with advanced pancreatic cancer to chemotherapy. Diffusion-weighted MRI was performed in 63 consecutive patients with advanced pancreatic cancer...

  • Gallbladder abnormalities in carcinoma of pancreatic head: findings on MR imaging. Zhang, Xiao; Mitchell, Donald; Byun, Jae; Verma, Sachit; Bergin, Diane; Witkiewicz, Agnes // Abdominal Imaging;Jul/Aug2009, Vol. 34 Issue 4, p507 

    Our objective is to study the gallbladder abnormalities on MR images associated with carcinoma of the pancreatic head. Thirty-six patients who had surgical resection of pancreatic head carcinoma were retrospectively analyzed regarding the appearance of the tumor and gallbladder on MR imaging...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics